CTLA-4 regulates expansion and differentiation of Th1 cells following induction of peripheral T cell tolerance

Journal of Immunology

Volumn 172, Issue 12, 2004, Pages 7442-7450

  Eagar, Todd N ^a,b   Turley, Danielle M ^a   Padilla, Josette ^a   Karandikar, Nitin J ^a,c   Tan, Litjen ^a   Bluestone, Jeffrey A ^b   Miller, Stephen D ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FREUND ADJUVANT; LIPOPOLYSACCHARIDE; MONOCLONAL ANTIBODY; OVALBUMIN; RECOMBINANT PROTEIN; SYNTHETIC PEPTIDE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; FLOW CYTOMETRY; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE DIFFERENTIATION; LYMPHOID TISSUE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH1 CELL;

EID: 2942586924     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.12.7442     Document Type: Article

References (29)

1. Miller, S. D., and W. J. Karpus. 1994. The immunopathogenesis and regulation of T-cell mediated demyelinating diseases. Immunol. Today 15:356.
2. Walker, L. S., and A. K. Abbas. 2002. The enemy within: keeping self-reactive T cells at bay in the periphery. Nat. Rev. Immunol. 2:11.
3. Van Parijs, L., V. L. Perez, and A. K. Abbas. 1998. Mechanisms of peripheral T cell tolerance. Novartis Found. Symp. 215:5.
4. Jenkins, M. K., C. A. Chen, G. Jung, D. L. Mueller, and R. H. Schwartz, 1990. Inhibition of antigen-specific proliferation of type 1 murine T cell clones after stimulation with immobilized anti-CD3 monoclonal antibody. J. Immunol. 144:16.
5. Fields, P., F. W. Fitch, and T. F. Gajewski. 1996. Control of T lymphocyte signal transduction through clonal anergy. J. Mol. Med. 74:673.
6. Schwartz, R. H. 1997. T cell clonal anergy. Curr. Opin. Immunol. 9:351.
7. Eagar, T. N., N. J. Karandikar, J. Bluestone, and S. D. Miller. 2002. The role of CTLA-4 in induction and maintenance of peripheral T cell tolerance. Eur. J. Immnol. 32:972.
8. Perez, V. L., L. V. Parijs, A. Biuckians, X. X. Zheng, T. B. Strom, and A. K. Abbas. 1997. Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. Immunity 6:411.
9. Frauwirth, K. A., M. L. Alegre, and C. B. Thompson. 2000. Induction of T cell anergy in the absence of CTLA-4/B7 interaction. J. Immunol. 164:2987.
10. Greenwald, R. J., V. A. Boussiotis, R. B. Lorsbach, A. K. Abbas, and A. H. Sharpe. 2001. CTLA-4 regulates induction of anergy in vivo. Immunity 14:145.
11. Wells, A. D., M. C. Walsh, J. A. Bluestone, and L. A. Turka. 2001. Signaling through CD28 and CTLA-4 controls two distinct forms of T cell anergy. J. Clin. Invest. 108:895.
12. Chatenoud, L., B. Salomon, and J. A. Bluestone. 2001. Suppressor T cells: they're back and critical for regulation of autoimmunity! Immunol. Rev. 182:149.
13. + regulatory T cells by oral antigen administration. J. Immunol. 167:4245.
14. Klein, L., K. Khazaie, and H. Von Boehmer. 2003. In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro. Proc. Natl. Acad. Sci. USA 100:8886.
15. Miller, S. D., R. P. Wetzig, and H. N. Claman. 1979. The induction of cell-mediated immunity and tolerance with protein antigens coupled to syngeneic lymphoid cells. J. Exp. Med. 149:758.
16. Jenkins, M. K., and R. H. Schwartz. 1987. Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J. Exp. Med. 165:302.
17. + Th1 but not Th2 cytokine responses, Int. Immunol. 6:721.
18. Kennedy, M. K., M. C. Dal Canto, J. L. Trotter, and S. D. Miller. 1988. Specific immune regulation of chronic-relapsing experimental allergic encephalomyelitis in mice. J. Immunol. 141:2986.
19. Kennedy, M. K., L. J. Tan, M. C. Dal Canto, and S. D. Miller. 1990. Regulation of the effector stages of experimental autoimmune encephalomyelitis via neuroantigen-specific tolerance induction. J. Immunol. 145:117.
20. Vanderlugt, C. L., T. N. Eagar, K. L. Neville, K. M. Nikcevich, J. A. Bluestone, and S. D. Miller. 2000. Pathologic role and temporal appearance of newly emerging autoepitopes in relapsing experimental autoimmune encephalomyelitis. J. Immunol. 164:670.
21. McRae, B. L., M. K. Kennedy, L. J. Tan, M. C. Dal Canto, and S. D. Miller. 1992. Induction of active and adoptive chronic-relapsing experimental autoimmune encephalomyelitis (EAE) using an encephalitogenic epitope of proteolipid protein. J. Neuroimmunol. 38:229.
22. Walunas, T. L., D. J. Lenschow, C. Y. Bakker, P. S. Linsley, G. J. Freeman, J. M. Green, C. B. Thompson, and J. A. Bluestone. 1994. CTLA-4 can function as a negative regulator of T cell activation. Immunity 1:405.
23. Miller, S. D., C. L. Vanderlugt, D. J. Lenschow, J. G. Pope, N. J. Karandikar, M. C. Dal Canto, and J. A. Bluestone. 1995. Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE. Immunity 3:739.
24. Khoruts, A., A. Mondino, K. A. Pape, S. L. Reiner, and M. K. Jenkins. 1998. A natural immunological adjuvant enhances T cell clonal expansion through a CD28-dependent, interleukin (IL)-2-independent mechanism. J. Exp. Med. 187:225.
25. Kennedy, M. K., L. J. Tan, M. C. Dal Canto, V. K. Tuohy, Z. J. Lu, J. L. Trotter, and S. D. Miller. 1990. Inhibition of murine relapsing experimental autoimmune encephalomyelitis by immune tolerance to proteolipid protein and its encephalitogenic peptides. J. Immunol. 144:909.
26. Tan, L. J., M. K. Kennedy, M. C. Dal Canto, and S. D. Miller. 1991. Successful treatment of paralytic relapses in adoptive experimental autoimmune encephalomyelitis via neuroantigen-specific tolerance. J. Immunol. 147:1797.
27. Bluestone, J. A. 1997. Is CTLA-4 a master switch for peripheral T cell tolerance? J. Immunol. 158:1989.
28. Lin, H., J. C. Rathmell, G. S. Gray, C. B. Thompson, J. M. Leiden, and M. L. Alegre. 1998. Cytotoxic T lymphocyte antigen 4 (CTLA4) blockade accelerates the acute rejection of cardiac allografts in CD28-deficient mice: CTLA4 can function independently of CD28. J. Exp. Med. 188:199.
29. Forsthuber, T., H. C. Yip, and P. V. Lehmann. 1996. Induction of Th1 and Th2 immunity in neonatal mice. Science 271:1728.